论文部分内容阅读
目的:探究小儿急性腹泻采用思密达联合宝乐安治疗的临床效果。方法:选择我院2012年3月~2013年3月收治急性腹泻患儿110例,随机分为55例治疗组和55例参照组,参照组仅采用思密达治疗,治疗组进行思密达与宝乐安联合治疗,治疗7天/疗程,对比治疗后两组的治疗效果。结果:经治疗,两组患儿都无不良反应,治疗组在大便恢复与呕吐消失的时间均比参照组少,治疗组的总有效率(98.18%)比参照组(89.10%)明显较高,差异明显(P<0.05),具有统计学意义。结论:采用思密达与宝乐安联合治疗小儿急性腹泻比单纯采用思密达治疗的临床效果较显著,具有临床推广意义。
Objective: To investigate the clinical effect of treatment of acute diarrhea in children with Smectite combined Baoluoan. Methods: A total of 110 children with acute diarrhea admitted to our hospital from March 2012 to March 2013 were randomly divided into 55 treatment groups and 55 reference groups. The treatment group was treated with Smectite only, Combined with Bao Luan treatment, treatment 7 days / course of treatment, the treatment of two groups after treatment compared. Results: After treatment, there was no adverse reaction in both groups. The recovery time of vomiting and stool recovery in the treatment group were less than those in the reference group. The total effective rate (98.18%) in the treatment group was significantly higher than that in the reference group (89.10%) , Significant difference (P <0.05), with statistical significance. Conclusion: The combination of Smecta and Bolean in the treatment of children with acute diarrhea than the simple treatment of Smecta clinical effect is more significant, with clinical significance.